Why diversity matters in management teams, and how to achieve it The biotech industry is suffering from a serious talent shortage, with start-ups in particular having an increasingly hard time filling […] December 14, 2022 · V-Bio Ventures
MedTech Flanders becomes part of MEDVIA, Flanders’ healthtech spearhead cluster Ghent, Belgium, 13 December 2022 – MEDVIA was founded in 2021 as Flanders’ spearhead cluster focused on health technologies. It is […] December 13, 2022 · Turnstone Communications
Cancer vaccines: not only treating tumors, but preventing them too The COVID-19 pandemic has brought vaccines back into the drug development spotlight, and mRNA vaccines are stealing the show with […] November 23, 2022 · V-Bio Ventures
Intressa Vascular secures EUR 18 million in financing to support the development of its multilayer Allay™ Aortic Stent for the treatment of aortic dissection Intressa Vascular is using its proprietary stent braiding technology to develop an innovative multilayer stent for the treatment of aortic […] October 25, 2022 · Turnstone Communications
Gene therapy challenges and the solutions in sight Dr. Federico Mingozzi is the CSO of Spark Therapeutics, the company behind Luxturna – the world’s first FDA-approved gene therapy […] October 19, 2022 · BioVox
We need more food and agtech start-ups – and we need them now! How are we going to feed an expected 10 billion people by 2050 in a sustainable way? It is a […] October 19, 2022 · V-Bio Ventures
BioVox: shining a light on Belgian biotech Beer, chocolate, and… biotech! When it comes to life sciences, Belgium excels. It consistently ranks as one of the world’s […] October 19, 2022 · BioVox
V-Bio Ventures leads Sibylla Biotech's EUR 23 million Series A to advance a novel therapeutic approach for undruggable diseases Ghent, Belgium, 4 October 2022 – V-Bio Ventures announces the successful close of a EUR 23 million Series A financing […] October 4, 2022 · V-Bio Ventures
VC opportunities for impact in the face of climate disaster Venture capitalists have a vital role to play in guiding our planet’s future. By investing in technological advances that remediate […] September 7, 2022 · V-Bio Ventures
KU Leuven spin-off AstriVax raises € 30 million to build vaccine platform • Closing on € 30 million, AstriVax has raised the largest amount of seed capital in the history of spin-offs […] August 25, 2022 · V-Bio Ventures
biotope by VIB: helping biotech startups take root in the ecosystem VIB’s new incubator program biotope fosters early biotech startups looking to impact people’s lives through agrifood innovation. Based in the […] August 24, 2022 · BioVox
New program fulfills the need for entrepreneurial talent in the life sciences The vibrant Belgian life sciences sector needs a constant influx of young and ambitious entrepreneurs to sustain its growth. The […] June 22, 2022 · Turnstone Communications
Belgian stakeholders make recommendations for urgently needed data science strategy in healthcare Antwerp, Belgium, 21 June 2022 – Inovigate, a consulting company for the healthcare industry, together with the Belgian Association of […] June 21, 2022 · Turnstone Communications
Is the dot-com bubble bursting all over again? The stock market value of biotech companies has been crashing lately, bitterly reminiscent of the dot-com bubble burst in the […] June 14, 2022 · V-Bio Ventures
Dr. Ajit Shetty: breaking down barriers in the life sciences A veteran of the life sciences industry, Dr. Ajit Shetty continues to have a huge impact on the ecosystem both […] May 18, 2022 · BioVox